{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:11:11Z","timestamp":1789085471591,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303635"],"award-info":[{"award-number":["82303635"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jare.2025.11.009","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T23:47:16Z","timestamp":1762645636000},"page":"559-572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["PRDM15 inhibits responses of Tissue-Resident memory T cells by activating PVR\/TIGIT axis to mediate gastric cancer immunosuppression"],"prefix":"10.1016","volume":"86","author":[{"given":"Xinyao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hantao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2025.11.009_b0005","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","article-title":"Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention","volume":"20","author":"Thrift","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jare.2025.11.009_b0010","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jare.2025.11.009_b0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41575-022-00726-3","article-title":"Updated epidemiology of gastrointestinal cancers in East Asia","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jare.2025.11.009_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104536","article-title":"Lymph node metastasis in cancer: Clearing the clouds to see the dawn","volume":"204","author":"Li","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jare.2025.11.009_b0025","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","volume":"186","author":"Gerstberger","year":"2023","journal-title":"Metastasitrm Cell"},{"key":"10.1016\/j.jare.2025.11.009_b0030","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.3390\/ijms21124427","article-title":"Combination of Ipilimumab and Nivolumab in Cancers: from Clinical Practice to Ongoing Clinical Trials","volume":"21","author":"Kooshkaki","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.jare.2025.11.009_b0035","first-page":"264","article-title":"Current treatment and recent progress in gastric cancer","volume":"71","author":"Joshi","year":"2021","journal-title":"CA A Cancer J Clinicians"},{"key":"10.1016\/j.jare.2025.11.009_b0040","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/oncolo\/oyad022","article-title":"Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS phase Ib\/II Umbrella Randomized Study Platform","volume":"28","author":"Ko","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/j.jare.2025.11.009_b0045","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1158\/1078-0432.CCR-13-1877","article-title":"Tumor-Infiltrating Lymphocytes Expressing the Tissue Resident memory Marker CD103 are Associated with increased Survival in High-Grade Serous Ovarian Cancer","volume":"20","author":"Webb","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jare.2025.11.009_b0050","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ni.3775","article-title":"Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer","volume":"18","author":"Ganesan","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jare.2025.11.009_b0055","doi-asserted-by":"crossref","first-page":"15221","DOI":"10.1038\/ncomms15221","article-title":"Induction of resident memory T cells enhances the efficacy of cancer vaccine","volume":"8","author":"Nizard","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2025.11.009_b0060","doi-asserted-by":"crossref","unstructured":"Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Savas P, Virassamy B, Ye C, Salim A, Mintoff CP, et al. Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis. Nat Med 2018;24:986\u201393. DOI: 10.1038\/s41591-018-0078-7.","DOI":"10.1038\/s41591-018-0078-7"},{"key":"10.1016\/j.jare.2025.11.009_b0065","doi-asserted-by":"crossref","first-page":"16741","DOI":"10.1073\/pnas.1107200108","article-title":"E-cadherin promotes accumulation of a unique memory CD8 T-cell population in murine salivary glands","volume":"108","author":"Hofmann","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.jare.2025.11.009_b0070","article-title":"CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer patients and are Tumor-Reactive Lymphocytes Enriched with Tc17","volume":"1","author":"Corgnac","year":"2020","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jare.2025.11.009_b0075","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ccell.2014.10.018","article-title":"The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function","volume":"26","author":"Johnston","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jare.2025.11.009_b0080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12943-019-1091-2","article-title":"Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4","volume":"18","author":"Qin","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jare.2025.11.009_b0085","doi-asserted-by":"crossref","unstructured":"Hasan F, Chiu Y, Shaw RM, Wang J, Yee C. Hypoxia acts as an environmental cue for the human tissue-resident memory T cell differentiation program. JCI Insight n.d.;6:e138970. DOI: 10.1172\/jci.insight.138970.","DOI":"10.1172\/jci.insight.138970"},{"key":"10.1016\/j.jare.2025.11.009_b0090","article-title":"CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer patients and are Tumor-Reactive Lymphocytes Enriched with Tc17","volume":"1","author":"Corgnac","year":"2020","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jare.2025.11.009_b0095","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1038\/s41467-020-17064-0","article-title":"PRDM15 is a key regulator of metabolism critical to sustain B-cell lymphomagenesis","volume":"11","author":"Mzoughi","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2025.11.009_b0100","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/eji.200839116","article-title":"A novel molecular interaction for the adhesion of follicular CD4 T cells to follicular DC","volume":"39","author":"Boles","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jare.2025.11.009_b0105","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1036214","article-title":"The checkpoint inhibitor TIGIT limits antitumor and antiviral CD8 + T cell responses","volume":"4","author":"Johnston","year":"2015","journal-title":"OncoImmunology"},{"key":"10.1016\/j.jare.2025.11.009_b0110","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/cdd.2012.141","article-title":"Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells","volume":"20","author":"Liu","year":"2013","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jare.2025.11.009_b0115","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1084\/jem.20030788","article-title":"Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule","volume":"198","author":"Bottino","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jare.2025.11.009_b0120","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.it.2016.10.002","article-title":"TIGIT: a Key Inhibitor of the Cancer Immunity Cycle","volume":"38","author":"Manieri","year":"2017","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jare.2025.11.009_b0125","doi-asserted-by":"crossref","unstructured":"Yu X, Harden K, C Gonzalez L, Francesco M, Chiang E, Irving B, et al. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat Immunol 2009;10:48\u201357. DOI: 10.1038\/ni.1674.","DOI":"10.1038\/ni.1674"},{"key":"10.1016\/j.jare.2025.11.009_b0130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nsmb.2209","article-title":"Symmetric dimethylation of H3R2 is a newly identified histone mark that supports euchromatin maintenance","volume":"19","author":"Migliori","year":"2012","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.jare.2025.11.009_b0135","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cjph.2022.10.002","article-title":"Numerical solutions and geometric attractors of a fractional model of the cancer-immune based on the Atangana-Baleanu-Caputo derivative and the reproducing kernel scheme","volume":"80","author":"Maayah","year":"2022","journal-title":"Chin J Phys"},{"key":"10.1016\/j.jare.2025.11.009_b0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.immunol.20.091101.091806","article-title":"The B7 Family of Ligands and its Receptors: New Pathways for Costimulation and Inhibition of Immune responses","volume":"20","author":"Carreno","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jare.2025.11.009_b0145","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its Ligands in Tolerance and Immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jare.2025.11.009_b0150","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer Immunoediting: Integrating Immunity\u2019s Roles in Cancer suppression and Promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jare.2025.11.009_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12105","article-title":"Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy","volume":"1284","author":"Vesely","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jare.2025.11.009_b0160","doi-asserted-by":"crossref","first-page":"42067","DOI":"10.18632\/oncotarget.5955","article-title":"PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47\/SIRP\u03b1 axis in HPV negative head and neck squamous cell carcinoma","volume":"6","author":"Yu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jare.2025.11.009_b0165","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/annonc\/mdy264","article-title":"Phase III, randomised trial of avelumab versus physician\u2019s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300","volume":"29","author":"Bang","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jare.2025.11.009_b0170","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1470-2045(16)00175-3","article-title":"Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial","volume":"17","author":"Muro","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jare.2025.11.009_b0175","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","article-title":"CD8+ T cell states in human cancer: insights from single-cell analysis","volume":"20","author":"Van Der Leun","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jare.2025.11.009_b0180","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1182\/blood-2018-01-825265","article-title":"TIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myeloma","volume":"132","author":"Guillerey","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jare.2025.11.009_b0185","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","article-title":"Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing","volume":"169","author":"Zheng","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jare.2025.11.009_b0190","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.immuni.2021.08.019","article-title":"Resident memory CD8+ T cells in regional lymph nodes mediate immunity to metastatic melanoma","volume":"54","author":"Molodtsov","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jare.2025.11.009_b0195","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1158\/2326-6066.CIR-22-0121","article-title":"Tissue-Resident memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition is Reversible by dual Antibody Blockade","volume":"11","author":"Pearce","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jare.2025.11.009_b0200","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1158\/2326-6066.CIR-18-0725","article-title":"Blockade of TIGIT\/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma","volume":"7","author":"Wu","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jare.2025.11.009_b0205","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.immuni.2022.12.010","article-title":"T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis","volume":"56","author":"Briukhovetska","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jare.2025.11.009_b0210","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1158\/0008-5472.CAN-17-0381","article-title":"CD155T\/TIGIT Signaling Regulates CD8+ T-cell Metabolism and Promotes Tumor Progression in Human Gastric Cancer","volume":"77","author":"He","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2025.11.009_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216381","article-title":"CD155 and its receptors in cancer immune escape and immunotherapy","volume":"573","author":"Zhou","year":"2023","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jare.2025.11.009_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116543","article-title":"CD155 expression in human breast cancer: Clinical significance and relevance to natural killer cell infiltration","volume":"231","author":"Triki","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.jare.2025.11.009_b0225","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1182\/blood-2008-08-173914","article-title":"ATM-ATR\u2013dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype","volume":"113","author":"Soriani","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jare.2025.11.009_b0230","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1158\/1078-0432.CCR-19-3925","article-title":"Tumor CD155 Expression is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma","volume":"26","author":"Lepletier","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jare.2025.11.009_b0235","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.immuni.2020.09.010","article-title":"CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells","volume":"53","author":"Braun","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jare.2025.11.009_b0240","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","article-title":"Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions","volume":"21","author":"Yi","year":"2022","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jare.2025.11.009_b0245","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1016\/S1470-2045(15)00007-8","article-title":"Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy","volume":"16","author":"Sharabi","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jare.2025.11.009_b0250","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1158\/1078-0432.CCR-15-2626","article-title":"T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML patients","volume":"22","author":"Kong","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jare.2025.11.009_b0255","doi-asserted-by":"crossref","first-page":"17960","DOI":"10.1073\/pnas.1209814109","article-title":"Crystal structure of the human PRMT5:MEP50 complex","volume":"109","author":"Antonysamy","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.jare.2025.11.009_b0260","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41419-022-05180-2","article-title":"MYBL1 induces transcriptional activation of ANGPT2 to promote tumor angiogenesis and confer sorafenib resistance in human hepatocellular carcinoma","volume":"13","author":"Zhu","year":"2022","journal-title":"Cell Death Dis"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S209012322500904X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S209012322500904X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:46:07Z","timestamp":1789083967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S209012322500904X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":52,"alternative-id":["S209012322500904X"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2025.11.009","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PRDM15 inhibits responses of Tissue-Resident memory T cells by activating PVR\/TIGIT axis to mediate gastric cancer immunosuppression","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2025.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}